Do Pediatric Vaccines Stand a Better
Chance of Protecting Against HIV?
Year after year, the IAVI Report team is inspired and amazed by the innovative science we get to write about, the personal motivation that drives scientists and advocates toward an HIV vaccine, and the extraordinary commitment of those working tirelessly to end AIDS. This issue, which closes out 2017, features a bit of all those things. There is a Q&A with Thomas Hope of Northwestern University about an effort he co-leads to develop a long-acting, implantable HIV prevention device. There are feature articles on the field’s considerations for planning an HIV vaccine trial in a pediatric population and on the increasing threat of HIV drug resistance. And there is another story about Marianne W. Mureithi, who after completing her studies abroad has returned to Kenya to contribute to HIV prevention research in an area hard hit by the virus. Finally, there is a story about Peter Sands, the newly appointed executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, which has spent billions of dollars raised from international governments to try to stamp out this deadly trio of diseases in places where they are most prevalent. Science, commitment, and motivation in action. READ MORE »